CURIOSITYSTREAM INC (CURI)
US23130Q1076 - Common Stock
Taking everything into account, CURI scores 3 out of 10 in our fundamental rating. CURI was compared to 72 industry peers in the Entertainment industry. The financial health of CURI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CURI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CURI had negative earnings in the past year.
In the past year CURI has reported a negative cash flow from operations.
In the past 5 years CURI always reported negative net income.
In the past 5 years CURI always reported negative operating cash flow.
1.2 Ratios
CURI's Return On Assets of -42.14% is on the low side compared to the rest of the industry. CURI is outperformed by 88.73% of its industry peers.
Looking at the Return On Equity, with a value of -59.08%, CURI is doing worse than 61.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.14% | ||
| ROE | -59.08% | ||
| ROIC | N/A |
ROA(3y)-32.91%
ROA(5y)-33.84%
ROE(3y)-44.62%
ROE(5y)-54.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 46.41%, CURI is in line with its industry, outperforming 50.70% of the companies in the same industry.
In the last couple of years the Gross Margin of CURI has declined.
The Profit Margin and Operating Margin are not available for CURI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CURI has been increased compared to 1 year ago.
CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CURI has an Altman-Z score of -0.93. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.93, CURI is not doing good in the industry: 77.46% of the companies in the same industry are doing better.
There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.93 |
ROIC/WACCN/A
WACC9.06%
2.3 Liquidity
CURI has a Current Ratio of 2.17. This indicates that CURI is financially healthy and has no problem in meeting its short term obligations.
CURI has a Current ratio of 2.17. This is in the better half of the industry: CURI outperforms 74.65% of its industry peers.
A Quick Ratio of 2.17 indicates that CURI has no problem at all paying its short term obligations.
CURI has a better Quick ratio (2.17) than 74.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.17 | ||
| Quick Ratio | 2.17 |
3. Growth
3.1 Past
CURI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.00%, which is quite impressive.
CURI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.10%.
Measured over the past years, CURI shows a quite strong growth in Revenue. The Revenue has been growing by 12.82% on average per year.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88%
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y12.82%
Revenue growth 5YN/A
Sales Q2Q%-19.39%
3.2 Future
The Earnings Per Share is expected to grow by 25.98% on average over the next years. This is a very strong growth
CURI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.98% yearly.
EPS Next Y78.43%
EPS Next 2Y37.62%
EPS Next 3Y27.13%
EPS Next 5Y25.98%
Revenue Next Year-8.3%
Revenue Next 2Y0.07%
Revenue Next 3Y4.68%
Revenue Next 5Y7.98%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CURI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
61.97% of the companies in the same industry are more expensive than CURI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.75 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CURI's earnings are expected to grow with 27.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.62%
EPS Next 3Y27.13%
5. Dividend
5.1 Amount
CURI has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 3.45, CURI pays a better dividend. On top of this CURI pays more dividend than 95.77% of the companies listed in the same industry.
CURI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.24.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
CURI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.62%
EPS Next 3Y27.13%
CURIOSITYSTREAM INC
NASDAQ:CURI (11/7/2024, 5:07:16 PM)
After market: 2 +0.07 (+3.63%)1.93
-0.7 (-26.62%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap105.38M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.14% | ||
| ROE | -59.08% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.41% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.17 | ||
| Quick Ratio | 2.17 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y78.43%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.1%
Revenue growth 3Y12.82%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y